Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
22 hedge funds and large institutions have $9.25M invested in Zosano Pharma Corporation in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
10% more funds holding
Funds holding: 20 → 22 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
52% less capital invested
Capital invested by funds: $19.3M → $9.25M (-$10.1M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$384K |
| 2 |
TI
Telemetry Investments
New York
|
+$237K |
| 3 |
WG
Winton Group
London,
United Kingdom
|
+$132K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$43.8K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$11.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$604K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$68K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$47.7K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$38K |
| 5 |
Jane Street
New York
|
-$36K |
ZSAN Hedge Fund Activity: Q3 2019 in Review
22 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q3 2019, worth a combined $9.25M — down 52% from $19.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ZSAN positions and 5 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $384K. The largest seller was Alyeska Investment Group, cutting an estimated $604K.
- 22 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q3 2019, up from 20 in Q2 2019.
- Funds reported $9.25M of Zosano Pharma Corporation stock for Q3 2019, down 52% quarter-over-quarter.
- 7 funds opened new Zosano Pharma Corporation positions in Q3 2019 and 5 closed out, a net change of +2 holders.
- The largest Zosano Pharma Corporation buyer in Q3 2019 was FNY Investment Advisers, an estimated $384K added.
- The largest Zosano Pharma Corporation seller in Q3 2019 was Alyeska Investment Group, an estimated $604K sold.
Based on aggregated 13F filings for Q3 2019.